A Novel Nanomedicine System TAR-AuNSs/Dox for the Treatment of Drug-Resistant Lymphoma

Figure 1

Characterization of TAR-AuNSs/Dox. (a) TEM image of TAR-AuNSs/Dox. (b) Size distributions and zeta potential of TAR-AuNSs/Dox tested by dynamic light scattering. (c) The UV-vis image of AuNSs, TAR, Dox, and TAR-AuNSs/Dox. (d) The LC and EE of Dox and TAR in TAR-AuNSs/Dox. (e) Dox release profiling of AuNSs/Dox and TAR-AuNSs/Dox at pH 7.4 and pH 6.5. (f) TAR release profiling of TAR-AuNSs/Dox at pH 7.4 and pH 6.5.

(a)

(b)

(c)

(d)

(e)

(f)